Selective killing of candidate AML stem cells by antibody targeting of IL1RAP.
- Division of Molecular Medicine and Gene Therapy
- Division of Clinical Genetics
- Stem Cell Center
Publishing year: 2013
Document type: Journal article
Publisher: American Society of Hematology
Key points IL1RAP is overexpressed on candidate AML stem cells and is a promising target for antibody-based therapy.
- ISSN: 1528-0020